Here's what I have been doing since I left MSU in 1979!!!!

I did my internship at Bronson Hospital in Kalamazoo, and if I remember, was among the first groups to take both the MT(ASCP) and the CLS(NCA) exams.
I passed both, believe it or not!

I worked at BMH for about three years and was then offered a position at Upjohn Diagnostics developing bioluminescent assays, which I accepted. I went to night school at Western Michigan and got an MBA in finance and business law. I then took a position monitoring clinical trials at Upjohn, followed by a stint in Good Clinical Practices/Good Laboratory Practices auditing. In 1988, I started in Drug Safety Surveillance and found my home. In 1996 I accepted the position of Manager of Drug Safety at Parke-Davis in Ann Arbor, later to become Pfizer, and in 2000 I accepted the position of Director of Drug Safety for Sankyo Pharma Development. I work between offices in NYC and Edison, NJ, and coordinate efforts with Munich, Germany and the head office in Tokyo.

My training as a Med Tech has served me very well in this position, and I prefer to hire MTs to work in the departments I manage. The reason I feel it works so well is that in Drug Safety we are not in the business of treating patients. We do not come into the picture until there is already a perceived problem. We are in the business of trying to diagnose why the patient is experiencing the reported events. Is it drug, underlying disease, interaction, life style, etc? Med Techs are primarily trained to diagnose.Often people feel that since Drug Safety is part of the pharmaceutical industry that pharmacists must be the most qualified candidates. In some cases, yes, but in Drug Safety their training in treating a previously diagnosed problem does not provide the kind of background that lends itself to using the data provided to come up with a reason for the problem. The same holds true for RNs. Again they are trained to treat, not diagnose.
I am truly thankful for the education I received at MSU.